All Stories

  1. People living with HIV co‐infected with the Kaposi Sarcoma‐associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma
  2. People living with HIV co-infected with the Kaposi sarcoma-associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma.
  3. Interaction between apolipoprotein E genotypes, excessive daytime sleepiness, and cognitive function in obstructive sleep apnea patients
  4. Environmental Changes and the Impact on the Human Infections by Dengue, Chikungunya and Zika Viruses in Northern Brazil, 2010–2019
  5. Antiviral Drug Resistance Mutations on the gag Gene in HIV
  6. The clinical course of hospitalized moderately ill COVID-19 patients is mirrored by routine hematologic tests and influenced by renal transplantation
  7. Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
  8. Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil
  9. Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.
  10. The Maturation of DNA Encoded Libraries: Opportunities for New Users
  11. Detection of coinfection with Chikungunya virus and Dengue virus serotype 2 in serum samples of patients in State of Tocantins, Brazil
  12. Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294
  13. HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals
  14. HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country
  15. Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial
  16. Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression
  17. Delay in Presentation of HIV and Initiation of Treatment Still a Challenge
  18. HIV-1 Patients Have Different Rates of Switching for the Coreceptor that permits infection
  19. Patients carry different genomic transcripts for the HIV retrovirus
  20. We Have Found a New Hepatitis B Recombinant Strain in Brazil
  21. Characteristics of the HIV-1 Infected Population in Brazil